Genetic research and genetic testing in Alzheimer's disease: a view from the bridge
Jennifer Williamson, Jill S Goldman and Richard Mayeux*
Correspondence *Gertrude H Sergievsky Center, Columbia University, 630 West 168th Street, New York, NY 10032, USA
Email rpm2@columbia.edu
In this Viewpoint, Williamson et al. highlight the distinction between genetic research and clinical testing in Alzheimer's disease. They consider how neurologists can bridge the gap between scientific advances and patient management, helping patients and their families to navigate this complex territory.
Full text of this article is available with one of the following:
- Personal subscription Purchase your own personal subscription to this journal. Already a subscriber? Please log in for immediate access.
- 7 day single article pass for US$18 In order to purchase this article you must be a registered user. Please register or log in.
- Site licence Learn more about institutional site licences
Current Subscribers
Please log in to access the full text article using the login box at the top of the page.